FAST vs SLNO · P/E 43, rev $4.59B vs P/E 27, $2.76B cap
Fastenal Company (FAST) versus Soleno Therapeutics Inc (SLNO) — a side-by-side from cached financials, not a winner call.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Soleno Therapeutics Inc (SLNO) is a biotechnology company listed on NASDAQ.
Latest reported FAST revenue for 2026-06-30 was $4.59B. Net income was $722.6M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
SLNO does not have a complete income-statement cache yet.
FAST currently screens at market cap $49.48B and trailing P/E 43.1. SLNO currently screens at market cap $2.76B and trailing P/E 27.5.
Not investment advice. Open the FAST and SLNO stock pages for the full models.
Not investment advice.